Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi
In a recent study published in The Journal of Investigative Dermatology, researchers developed a genetic treatment targeting the causal NRAS c.181C>A mutation in congenital melanocytic naevus (CMN) using small interfering…
Read More...
Read More...